NVO vs PFE
Novo Nordisk A/S vs Pfizer Inc. — AI-powered side-by-side comparison
| Metric | NVO | PFE |
|---|---|---|
| AI Score | 56 | 68 |
| Price | $49.48 | $24.19 |
| P/E Ratio | 11.75× | 18.44× |
| ROE | 66.4% | 8.4% |
| Revenue Growth YoY | 8.1% | 1.4% |
| Gross Margin | 81.8% | 74.8% |
| Debt / Equity | 0.67× | 0.75× |
| Dividend Yield | 3.7% | 7.1% |
| RSI (14) | 65.6 | 44.8 |
| Beta | 1.8569 | 0.2851 |
| Expected Upside | +25.9% | +7.7% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
NVO Full Analysis
PFE Full Analysis